Blog Posts

News Alert

Virginia Governor Vetoes 340B Contract Pharmacy Access Law that Nearly Unanimously Passed State Legislature

Virginia Gov. Glenn Youngkin (R) vetoed 340B contract pharmacy access legislation after the state senate rejected his proposed amendment.
Virginia Gov. Glenn Youngkin (R) late Friday vetoed a bill that would have prohibited drugmaker contract pharmacy restrictions on grantee [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

On Final Day of Session, Missouri House Passes 340B Contract Pharmacy Access Bill, Sends to Governor’s Desk

Missouri House 340B
The Missouri House overwhelmingly passed a 340B contract pharmacy access bill on the final day of the state's legislative session.
On the final day of Missouri’s legislative session, lawmakers overwhelmingly passed a bill to bar drugmaker 340B contract pharmacy restrictions [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Kansas Governor Rejects Provision to Delay New 340B Contract Pharmacy Protections

Kansas Gov. Laura Kelly (D) vetoed provisions of a bill that would have delayed a 340B contract pharmacy access law from taking effect.
A Kansas law that prohibits drugmaker 340B contract pharmacy restrictions is set to take effect July 1, as result of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maryland Is Sixth State to Enact 340B Contract Pharmacy Access Law

Maryland Gov. Wes Moore (right) will make Maryland the sixth state to prohibit drugmaker 340B contract pharmacy restrictions when he signs legislation today.
Maryland Gov. Wes Moore (D) this morning is signing legislation to make Maryland the sixth state to prohibit drugmaker 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CVS Cites 340B Contract Pharmacy Restrictions in 19% Income Drop in Its Pharmacy Services

CVS Health said drugmaker 340B contract pharmacy restrictions contributed to a decline in the company's pharmacy services revenue.
CVS Health recently cited drug manufacturers’ contract pharmacy restriction as one of the causes for a 19% year-over-year income decline [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Are You Prepared for an Office of Pharmacy Affairs (OPA) Audit?

SPONSORED CONTENT

All entities who participate in the 340B program are subject to an Office of Pharmacy Affairs (OPA) audit regardless of entity type, size or volume of transactions.  For the last five years, HRSA’s OPA has been completing approximately 200 audits a year and

Read More »

Federal Court Sets April 2025 Trial for AstraZeneca’s Arkansas 340B Law Challenge Amid State Enforcement Actions

The trial for drugmaker AstraZeneca's lawsuit against Arkansas' 340B contract pharmacy access law will take place in April 2025.
A federal judge scheduled an April 2025 trial date for AstraZeneca’s lawsuit against Arkansas’ 340B contract pharmacy access law as [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Sales Increased 17% to $124B in 2023, Drug Industry Consulting Firm Finds 

Analysts from IQVIA found that 340B wholesale acquisition cost sales increased by 17% from 2022 to 2023.
The 340B program continued to expand in 2023, exceeding $124 billion in wholesale acquisition cost (WAC) sales—up from $107 billion [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four States May Act on 340B Contract Pharmacy Access Bills this Week

Missouri is one of four states expected to act on a high-profile 340B contract pharmacy access bill or amendment this week.
This week will see major legislative action on up to four state 340B contract pharmacy access bills—including on two controversial [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Draft Senate Bill Would Pay Hospitals to Stockpile Certain Generic Drugs if They Forgo 340B Discounts, Meet New Contracting Requirements

Sen. Mike Crapo (R-Idaho), ranking member of the Senate Finance Committee, said a bipartisan draft bill would "take meaningful strides toward mitigating and preventing prescription drug shortages."
A new Senate draft drug shortages bill would offer bonus payments to hospitals that stockpile certain generic drugs and agree [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »